Clinical Data Beam posts positive data on base editing treatment for AATD BioPharma DiveUpdated data showed the biotech's approach to the rare lung and liver condition helped restore functional protective proteins in a small study.Clinical DataRare DiseaseRead full story pharminent March 25, 2026 (Last updated: March 26, 2026) BioPharma Dive Updated data showed the biotech’s approach to the rare lung and liver condition helped restore functional protective proteins in a small study. Clinical DataRare DiseaseRead full story Please leave this field emptySign up to receive free daily digest Check your inbox or spam folder to confirm your subscription. Post navigation Previous: Sarepta sees early success with RNAi drugs from ArrowheadNext: Maze tumbles despite positive data for kidney disease drug Related Stories Clinical Data Parsortix study shows promise for ADC target detection pharminent August 3, 2026 Clinical Data Novo setback casts doubt on a new way to treat heart disease pharminent July 31, 2026 Clinical Data Altimmune rises as GLP-1/GIP drug curbs heavy drinking in mid-stage study pharminent July 28, 2026
